Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Betoptic S and Timolol Gel in Pediatric Glaucoma
NCT00061542Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2003
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betaxolol and timolol maleate gel + placebo in Glaucoma and ocular hypertension (3 arms), sponsored by Alcon Inc. Primary endpoint: Mean change from baseline in Intraocular Pressure at 12 weeks. Started Jan 2003; status: completed.
02
Drugs
betaxololtimolol maleate gel + placebo
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00061542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061542.